J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):e84-e89. doi: 10.1016/j.japh.2021.05.003. Epub 2021 May 18.
Pharmacy is among the most regulated of health professions on the basis of both word count and restrictions. State-level restrictions limit the ability of pharmacists to be fully engaged as members of the health care team.
This paper aimed to create a simple benchmark-the Pharmacy Regulatory Innovation Index (PRII)-that takes into account the scope-of-practice allowances that a state provides to pharmacists and the overall regulatory burden for the pharmacy profession using 10 western states as a sample.
A scorecard was developed on the basis of the activities reported as necessary for pharmacists to fully engage in the Pharmacists' Patient Care Process (PPCP). The laws and regulations of 10 western states were analyzed using plain-text interpretation.
The 10 western states fall into 3 of 4 distinct quadrants. Three states appear in the highly regulated, low-innovation quadrant (Oregon, California, and Nevada), and 2 states appear in the low-regulated, high-innovation quadrant (Idaho and Washington). The remaining 5 states fall in the low-regulated, low-innovation quadrant (Alaska, Hawaii, Montana, Utah, and Wyoming).
The PRII has been created to assess a state's regulatory burden and its scope-of-practice allowances, using the PPCP as a guide for innovation. States can use the PRII tool to benchmark their regulations in comparison with those of peer states and identify opportunities for improvement.
基于字数和限制，药剂学是卫生专业中受到监管最多的专业之一。州级限制限制了药剂师作为医疗团队成员充分参与的能力。
本文旨在创建一个简单的基准，即药房监管创新指数（PRII），该指数考虑了一个州为药剂师提供的执业范围津贴以及整个药房行业的监管负担，以 10 个西部州作为样本。
根据药剂师充分参与药剂师患者护理流程（PPCP）所需的活动制定了记分卡。使用纯文本解释分析了 10 个西部州的法律法规。
这 10 个西部州分为 4 个象限中的 3 个。有三个州处于高度监管、低创新象限（俄勒冈州、加利福尼亚州和内华达州），有两个州处于低监管、高创新象限（爱达荷州和华盛顿州）。其余 5 个州位于低监管、低创新象限（阿拉斯加、夏威夷、蒙大拿、犹他州和怀俄明州）。
创建 PRII 是为了评估一个州的监管负担及其执业范围津贴，以 PPCP 作为创新指南。各州可以使用 PRII 工具来比较其与同行州的法规，并确定改进的机会。
